Under the terms of the agreement, the companies plan to initiate a Phase 1/2 study evaluating the combination of tafasitamab, plamotamab and lenalidomide ... Nov 13
Glenmark has been granted final approval by the U.S. FDA for Tacrolimus Capsules USP, the generic version of Prograf Capsules, of Astellas Pharm US, ... Nov 11
-Advertisements-